Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory Action

Documenti analoghi

• Cover Image, Volume 33, Issue 9
  di: Samantha Lane, et al.
  Pubblicazione: (2024)
• Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis
  di: Jeremy P. Brown, et al.
  Pubblicazione: (2024)
• Post‐Market Evidence for Cancer Medicines in Regulatory and Clinical Decision‐Making: A Scoping Review
  di: Eliza J. McEwin, et al.
  Pubblicazione: (2025)
• PMDA Perspective on RWD/RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage
  di: Kazuhiro Kajiyama, et al.
  Pubblicazione: (2024)
• Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations
  di: Thomas Goedecke, et al.
  Pubblicazione: (2024)